- Home
- PR vs SNN Comparison
PR vs SNN Comparison
Compare PR & SNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PR | SNN |
|---|---|---|
| Founded | 2015 | 1856 |
| Country | United States | United Kingdom |
| Employees | N/A | 16988 |
| Industry | Oil & Gas Production | Industrial Specialties |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 17.6B | 14.3B |
| IPO Year | 2016 | N/A |
Fundamental Metrics
Financial Performance| Metric | PR | SNN |
|---|---|---|
| Price | $20.70 | $29.60 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 19 | 2 |
| Target Price | $22.35 | ★ $36.25 |
| AVG Volume (30 Days) | ★ 12.8M | 1.3M |
| Earning Date | 05-06-2026 | 03-16-2026 |
| Dividend Yield | ★ 2.96% | 2.48% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.05 | N/A |
| Revenue | ★ $5,065,211,000.00 | N/A |
| Revenue This Year | $20.94 | $8.58 |
| Revenue Next Year | $7.51 | $5.60 |
| P/E Ratio | $404.70 | ★ $64.97 |
| Revenue Growth | ★ 1.29 | N/A |
| 52 Week Low | $11.92 | $28.23 |
| 52 Week High | $22.68 | $38.79 |
Technical Indicators
Market Signals| Indicator | PR | SNN |
|---|---|---|
| Relative Strength Index (RSI) | 51.39 | 36.48 |
| Support Level | $19.25 | N/A |
| Resistance Level | $21.99 | $33.89 |
| Average True Range (ATR) | 0.56 | 0.58 |
| MACD | -0.14 | -0.09 |
| Stochastic Oscillator | 36.16 | 17.70 |
Price Performance
Historical ComparisonAbout PR Permian Resources Corporation
Permian Resources Corp is an independent oil and natural gas company focused on generating outsized returns to stakeholders through the responsible acquisition, optimization, and development of oil and liquids-rich natural gas assets. The Company's assets and operations are concentrated in the core of the Permian Basin, and its properties consist of large, contiguous acreage blocks located in West Texas and New Mexico.
About SNN Smith & Nephew SNATS Inc.
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 41% of the UK-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.